PerpEquities

Equity

Exelixis, Inc. (EXEL) perpetual futures

Exelixis is a US biotechnology company focused on developing and commercializing cancer therapies, including CABOMETYX and COMETRIQ.

+0.2%NASDAQ closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NASDAQ:EXEL

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D+0.16%
5D-3.63%
1M+9.70%
6M+36.30%
YTD+28.25%
1Y+44.09%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeEXEL-USDTPlanned------USDT-
Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 2h ago
Market cap
$14.1B
Updated 2h ago
Revenue
$2.4B
Trailing 12 months
Revenue growth
+10%
Next fiscal year
Profit margin
+35.3%
P/E
17.1
Peer P/E -6.7
Free cash flow
$1.2B
Trailing 12 months
More metrics
Net income
$860.6M
Trailing 12 months
P/S
5.8
Peer P/E
-6.7
Similar listed perps
Revenue estimate
$2.6B
Next fiscal year
Earnings
2026-11-03
Revenue est. $649.6M · Updated 2h ago
Dividend
-

Fundamental detail

Annual + quarterly
Latest revenue$2.3B
Net margin+33.7%
Free cash flow$844.3M
Net debt-$309.5M
2020$987.5M
2021$1.4B
2022$1.6B
2023$1.8B
2024$2.2B
2025$2.3B
PeriodRevenueGrowthNet incomeFCF
2020$987.5M+2%$111.8M$178.6M
2021$1.4B+45%$231.1M$336.6M
2022$1.6B+12%$182.3M$224.2M
2023$1.8B+14%$207.8M$170.4M
2024$2.2B+18%$521.3M$633.8M
2025$2.3B+7%$782.6M$844.3M
PeriodGross marginOperating marginNet marginROEROA
2020+96.3%+11.1%+11.3%+5.9%+5.2%
2021+96.3%+20.0%+16.1%+10.5%+8.8%
2022+96.4%+12.5%+11.3%+7.3%+5.9%
2023+96.0%+9.3%+11.4%+9.2%+7.1%
2024+96.5%+27.9%+24.0%+23.2%+17.7%
2025+96.4%+37.6%+33.7%+36.2%+27.5%
PeriodCashDebtNet debtCurrent ratio
2020$319.2M$49.1M-$270.1M7.06
2021$647.2M$51.3M-$595.9M5.43
2022$501.2M$190.2M-$311M4.99
2023$263M$189.9M-$73.1M3.34
2024$217.4M$190.8M-$26.6M3.63
2025$482.5M$173M-$309.5M3.56
PeriodMarket capEnterprise valueP/SP/E
2020$6.2B$5.9B6.355.8
2021$5.8B$5.2B4.025.0
2022$5.2B$4.8B3.228.1
2023$7.6B$7.6B4.236.9
2024$9.9B$9.8B4.518.9
2025$11.8B$11.5B5.115.1
Q3 2024$539.5M
Q4 2024$566.8M
Q1 2025$555.4M
Q2 2025$568.3M
Q3 2025$597.8M
Q4 2025$598.7M
Q1 2026$610.8M
Q2 2026$628.7M
PeriodRevenueGrowthNet incomeFCF
Q3 2024$539.5M+14%$118M$262.1M
Q4 2024$566.8M+18%$139.9M$226.3M
Q1 2025$555.4M+31%$159.6M$189M
Q2 2025$568.3M-11%$184.8M$45.4M
Q3 2025$597.8M+11%$193.6M$288.8M
Q4 2025$598.7M+6%$244.5M$332.4M
Q1 2026$610.8M+10%$210.5M$249.8M
Q2 2026$628.7M+11%$212.1M$309.8M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+96.8%+25.2%+21.9%+5.2%+4.0%
Q4 2024+96.5%+28.8%+24.7%+6.2%+4.7%
Q1 2025+96.5%+33.6%+28.7%+7.5%+5.6%
Q2 2025+96.6%+37.6%+32.5%+9.1%+6.9%
Q3 2025+96.9%+39.6%+32.4%+9.0%+6.9%
Q4 2025+95.6%+39.3%+40.8%+11.3%+8.6%
Q1 2026+96.7%+41.1%+34.5%+10.9%+8.1%
Q2 2026+96.7%+39.5%+33.7%+11.5%+8.5%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$258.3M$194.4M-$63.9M3.93
Q4 2024$217.4M$190.8M-$26.6M3.63
Q1 2025$183.8M$187.1M$3.4M3.50
Q2 2025$164.4M$179.8M$15.4M3.51
Q3 2025$376.3M$176.5M-$199.8M3.75
Q4 2025$482.5M$173M-$309.5M3.56
Q1 2026$226.2M$169.5M-$56.6M3.26
Q2 2026$281.4M$165.9M-$115.5M3.46
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$7.4B$7.4B13.715.8
Q4 2024$9.5B$9.4B16.717.3
Q1 2025$9.6B$9.6B17.415.2
Q2 2025$12.6B$12.6B22.117.0
Q3 2025$10.8B$10.6B18.013.9
Q4 2025$11.8B$11.5B19.812.0
Q1 2026$11.3B$11.3B18.613.5
Q2 2026$14B$13.9B22.316.4

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$628.7MQ2 2026
$159.3M$318.6M$477.9M$637.2MQ3 2023: $471.9MQ4 2023: $479.7MQ1 2024: $425.2MQ2 2024: $637.2MQ3 2024: $539.5MQ4 2024: $566.8MQ1 2025: $555.4MQ2 2025: $568.3MQ3 2025: $597.8MQ4 2025: $598.7MQ1 2026: $610.8MQ2 2026: $628.7MQ3 2023Q2 2026
Net income$212.1MQ2 2026
$61.1M$122.3M$183.4M$244.5MQ3 2023: $1MQ4 2023: $85.5MQ1 2024: $37.3MQ2 2024: $226.1MQ3 2024: $118MQ4 2024: $139.9MQ1 2025: $159.6MQ2 2025: $184.8MQ3 2025: $193.6MQ4 2025: $244.5MQ1 2026: $210.5MQ2 2026: $212.1MQ3 2023Q2 2026
EBITDA$262.7MQ2 2026
$70.9M$141.8M$212.8M$283.7MQ3 2023: $12.1MQ4 2023: $109.6MQ1 2024: $68.7MQ2 2024: $283.7MQ3 2024: $195.3MQ4 2024: $171.1MQ1 2025: $213MQ2 2025: $237.8MQ3 2025: $259.8MQ4 2025: $242.9MQ1 2026: $274.6MQ2 2026: $262.7MQ3 2023Q2 2026
Free cash flow$309.8MQ2 2026
$81.2M$164.9M$248.6M$332.4MQ3 2023: $23.5MQ4 2023: -$2.6MQ1 2024: $50.6MQ2 2024: $94.7MQ3 2024: $262.1MQ4 2024: $226.3MQ1 2025: $189MQ2 2025: $45.4MQ3 2025: $288.8MQ4 2025: $332.4MQ1 2026: $249.8MQ2 2026: $309.8MQ3 2023Q2 2026
EPS$0.82Q2 2026
$0.22$0.44$0.66$0.88Q3 2023: $0Q4 2023: $0.27Q1 2024: $0.12Q2 2024: $0.77Q3 2024: $0.4Q4 2024: $0.47Q1 2025: $0.55Q2 2025: $0.65Q3 2025: $0.7Q4 2025: $0.88Q1 2026: $0.79Q2 2026: $0.82Q3 2023Q2 2026
Cash / Debt$281.4MQ2 2026
$120.6M$241.2M$361.9M$482.5MQ3 2023 · Cash: $396.9MQ3 2023 · Debt: $190.9MQ4 2023 · Cash: $263MQ4 2023 · Debt: $189.9MQ1 2024 · Cash: $259.6MQ1 2024 · Debt: $201.5MQ2 2024 · Cash: $198.5MQ2 2024 · Debt: $198MQ3 2024 · Cash: $258.3MQ3 2024 · Debt: $194.4MQ4 2024 · Cash: $217.4MQ4 2024 · Debt: $190.8MQ1 2025 · Cash: $183.8MQ1 2025 · Debt: $187.1MQ2 2025 · Cash: $164.4MQ2 2025 · Debt: $179.8MQ3 2025 · Cash: $376.3MQ3 2025 · Debt: $176.5MQ4 2025 · Cash: $482.5MQ4 2025 · Debt: $173MQ1 2026 · Cash: $226.2MQ1 2026 · Debt: $169.5MQ2 2026 · Cash: $281.4MQ2 2026 · Debt: $165.9MQ3 2023Q2 2026
CashDebt
Profitability+96.7%Q2 2026
+21.5%+46.8%+72.0%+97.2%Q3 2023 · Gross margin: +96.0%Q4 2023 · Gross margin: +95.5%Q1 2024 · Gross margin: +95.0%Q2 2024 · Gross margin: +97.2%Q3 2024 · Gross margin: +96.8%Q4 2024 · Gross margin: +96.5%Q1 2025 · Gross margin: +96.5%Q2 2025 · Gross margin: +96.6%Q3 2025 · Gross margin: +96.9%Q4 2025 · Gross margin: +95.6%Q1 2026 · Gross margin: +96.7%Q2 2026 · Gross margin: +96.7%Q3 2023 · Operating margin: -3.7%Q4 2023 · Operating margin: +17.1%Q1 2024 · Operating margin: +6.9%Q2 2024 · Operating margin: +43.3%Q3 2024 · Operating margin: +25.2%Q4 2024 · Operating margin: +28.8%Q1 2025 · Operating margin: +33.6%Q2 2025 · Operating margin: +37.6%Q3 2025 · Operating margin: +39.6%Q4 2025 · Operating margin: +39.3%Q1 2026 · Operating margin: +41.1%Q2 2026 · Operating margin: +39.5%Q3 2023 · Net margin: +0.2%Q4 2023 · Net margin: +17.8%Q1 2024 · Net margin: +8.8%Q2 2024 · Net margin: +35.5%Q3 2024 · Net margin: +21.9%Q4 2024 · Net margin: +24.7%Q1 2025 · Net margin: +28.7%Q2 2025 · Net margin: +32.5%Q3 2025 · Net margin: +32.4%Q4 2025 · Net margin: +40.8%Q1 2026 · Net margin: +34.5%Q2 2026 · Net margin: +33.7%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+10.6%Q2 2026
-0.5%+9.9%+20.3%+30.6%Q3 2024: +14.3%Q4 2024: +18.2%Q1 2025: +30.6%Q2 2025: -10.8%Q3 2025: +10.8%Q4 2025: +5.6%Q1 2026: +10.0%Q2 2026: +10.6%Q3 2023Q2 2026
Shares outstanding259.7MQ2 2026
79.8M159.6M239.4M319.2MQ3 2023: 319.2MQ4 2023: 313MQ1 2024: 305.5MQ2 2024: 294MQ3 2024: 291.5MQ4 2024: 293.5MQ1 2025: 288.2MQ2 2025: 284.4MQ3 2025: 278.5MQ4 2025: 281.9MQ1 2026: 267.3MQ2 2026: 259.7MQ3 2023Q2 2026
Valuation16.4Q2 2026
413.8827.71,241.51,655.3Q3 2023 · P/E: 1,655.3Q4 2023 · P/E: 21.4Q1 2024 · P/E: 49.4Q2 2024 · P/E: 7.2Q3 2024 · P/E: 15.8Q4 2024 · P/E: 17.3Q1 2025 · P/E: 15.2Q2 2025 · P/E: 17.0Q3 2025 · P/E: 13.9Q4 2025 · P/E: 12.0Q1 2026 · P/E: 13.5Q2 2026 · P/E: 16.4Q3 2023 · P/S: 14.6Q4 2023 · P/S: 15.4Q1 2024 · P/S: 16.8Q2 2024 · P/S: 10.2Q3 2024 · P/S: 13.7Q4 2024 · P/S: 16.7Q1 2025 · P/S: 17.4Q2 2025 · P/S: 22.1Q3 2025 · P/S: 18.0Q4 2025 · P/S: 19.8Q1 2026 · P/S: 18.6Q2 2026 · P/S: 22.3Q3 2023Q2 2026
P/EP/S
Revenue$2.3B2025
$580M$1.2B$1.7B$2.3B2018: $853.8M2019: $967.8M2020: $987.5M2021: $1.4B2022: $1.6B2023: $1.8B2024: $2.2B2025: $2.3B20182025
Net income$782.6M2025
$195.6M$391.3M$586.9M$782.6M2018: $690.1M2019: $321M2020: $111.8M2021: $231.1M2022: $182.3M2023: $207.8M2024: $521.3M2025: $782.6M20182025
EBITDA$921.8M2025
$230.4M$460.9M$691.3M$921.8M2018: $443.8M2019: $369.5M2020: $119.2M2021: $307.8M2022: $255.2M2023: $283.2M2024: $718.8M2025: $921.8M20182025
Free cash flow$844.3M2025
$211.1M$422.2M$633.3M$844.3M2018: $382.4M2019: $514.1M2020: $178.6M2021: $336.6M2022: $224.2M2023: $170.4M2024: $633.8M2025: $844.3M20182025
EPS$2.782025
$0.7$1.39$2.09$2.782018: $2.212019: $1.022020: $0.352021: $0.722022: $0.562023: $0.652024: $1.762025: $2.7820182025
Cash / Debt$482.5M2025
$161.8M$323.6M$485.4M$647.2M2018 · Cash: $314.8M2018 · Debt: $14.9M2019 · Cash: $266.5M2019 · Debt: $50.7M2020 · Cash: $319.2M2020 · Debt: $49.1M2021 · Cash: $647.2M2021 · Debt: $51.3M2022 · Cash: $501.2M2022 · Debt: $190.2M2023 · Cash: $263M2023 · Debt: $189.9M2024 · Cash: $217.4M2024 · Debt: $190.8M2025 · Cash: $482.5M2025 · Debt: $173M20182025
CashDebt
Profitability+96.4%2025
+24.2%+48.5%+72.7%+96.9%2018 · Gross margin: +96.9%2019 · Gross margin: +96.6%2020 · Gross margin: +96.3%2021 · Gross margin: +96.3%2022 · Gross margin: +96.4%2023 · Gross margin: +96.0%2024 · Gross margin: +96.5%2025 · Gross margin: +96.4%2018 · Operating margin: +51.4%2019 · Operating margin: +38.2%2020 · Operating margin: +11.1%2021 · Operating margin: +20.0%2022 · Operating margin: +12.5%2023 · Operating margin: +9.3%2024 · Operating margin: +27.9%2025 · Operating margin: +37.6%2018 · Net margin: +80.8%2019 · Net margin: +33.2%2020 · Net margin: +11.3%2021 · Net margin: +16.1%2022 · Net margin: +11.3%2023 · Net margin: +11.4%2024 · Net margin: +24.0%2025 · Net margin: +33.7%20182025
Gross marginOperating marginNet margin
Revenue growth+7.0%2025
+11.3%+22.7%+34.0%+45.3%2019: +13.3%2020: +2.0%2021: +45.3%2022: +12.3%2023: +13.6%2024: +18.5%2025: +7.0%20182025
Shares outstanding281.9M2025
81.1M162.3M243.4M324.6M2018: 312.8M2019: 315M2020: 318M2021: 322.4M2022: 324.6M2023: 321.5M2024: 296.1M2025: 281.9M20182025
Valuation15.12025
13.927.941.855.82018 · P/E: 8.52019 · P/E: 16.62020 · P/E: 55.82021 · P/E: 25.02022 · P/E: 28.12023 · P/E: 36.92024 · P/E: 18.92025 · P/E: 15.12018 · P/S: 6.92019 · P/S: 5.52020 · P/S: 6.32021 · P/S: 4.02022 · P/S: 3.22023 · P/S: 4.22024 · P/S: 4.52025 · P/S: 5.120182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-03
Revenue est. $649.6M · Updated 2h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20273.51$2.6B+10%10
FY 20284.15$2.9B+25%9
FY 20294.97$3.3B+40%8
FY 20305.65$3.5B+52%4
FY 20314.73$3.1B+36%5
Q2 20270.95$671.4M+7%4

Company events

6
2026-11-03EarningsActual - / Estimate 0.89-
2026-08-05EarningsActual 0.91 / Estimate 0.85Beat
2026-05-05EarningsActual 0.87 / Estimate 0.77Beat
2026-02-10EarningsActual 0.94 / Estimate 0.77Beat
2025-11-04EarningsActual 0.78 / Estimate 0.69Beat
2025-07-28EarningsActual 0.75 / Estimate 0.65Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
IONQ$14B56.8-8.7-573.6%17TKO$14.5B2.764.2+4.3%1BMNR$14.7B239.8-1.1-14,306.6%22SMMT$14.7B--16.40.0%1SHEIN$13.5B0.312.5+3.7%13ECHO$14.9B1.0-4.7-38.7%2CHYM$12.9B5.5-599.1-0.8%1QNT$12.9B418.0-20.4-1,452.5%15

Analyst track record

How the analysts covering EXEL have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings136436
Analysts2635
Buy / hold / sell51 / 80 / 5249 / 176 / 11
Upgrades / downgrades / initiations1 / 4 / 63 / 9 / 13
Price targets hit / missed99 / 3 (97%)366 / 4 (99%)
Avg. return after a rating (TipRanks)+22.3%+62.8%
Best / worst call+87.4% / -12.2%+212.3% / -12.2%

After buy calls on this stock: not enough measured cases yet

Latest ratings

DateAnalystCallTarget
Sep 14, 2026Gregory RenzaTruist FinancialHoldMaintained–article ↗
Sep 11, 2026Stephen WilleyStifel NicolausHoldMaintained–article ↗
Sep 11, 2026Jason GerberryBank of America SecuritiesSellMaintained$41.00article ↗
Sep 11, 2026Andy HsiehWilliam BlairBuyReiterated–article ↗
Sep 11, 2026David LebowitzBMO CapitalHoldMaintained$54.00article ↗

TipRanks data via FMP · computed Sep 15, 2026 · 136 ratings

Embed this asset

EXEL perpetuals · perpequities.comEXEL perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/exel-perp"><img src="https://perpequities.com/badge/exel-perp.svg" width="240" height="64" alt="EXEL perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of EXEL perps

Weekly digest by email

The listings, funding and moves that matter for EXEL — one email every Sunday.

Watchlist and alerts

Price and funding alerts for EXEL, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X